News

C&EN19h
Biodegradable Copolymer for Stimuli-Responsive Sustained Release of Doxorubicin
† Polymer Research Centre, Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal 741246, India ‡ Department of Biological Sciences, Indian ...
The Lancet3d
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre ...
bDepartment of Pediatrics, University of Washington, Seattle, WA, USA cDepartment of Biostatistics, University of Washington, Seattle, WA, USA dTranslational Medicine Research Institute, The Hospital ...
C&EN5d
Release of Magnetic Nanoparticles from Cell-Encapsulating Biodegradable Nanobiomaterials
# Current address: The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China, and ...
BMJ6d
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
Methods: This 14-week, multicentre, non-randomised, single-blind ... supporting the need for larger, randomised, controlled studies of IL1 antagonism such as with rilonacept for this clinical ...
IEEE11d
Consistency Algorithm-Based SOC Balancing Scheme of Retired Non-Equal Capacity Lithium Battery in Virtual Synchronous Generator Controlled Microgrids
However, the traditional virtual synchronous generator (VSG) control scheme and the existing VSG-based SOC balancing scheme fail to achieve the SOC balancing of non-equal capacity RLB in ...
The Lancet11d
Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo ...
hInstitute for Cardiometabolism and Nutrition, Sorbonne Université, Hôpital Pitié Salpêtrière, Paris, France ...
BMJ13d
Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial
Methods and analysis The trial has a multicentre, non-inferiority, double-blinded design. One hundred and twenty patients diagnosed with LNB according to European Federation of Neurological Societies ...
Medscape17d
Efficacy and Tolerability of Oxycodone Hydrochloride Controlled-Release Tablets in Moderate to Severe Cancer Pain
This was an open-label, multicentre trial. Ten hospitals participated in this trial. It was approved by the investigators' institutional review board. The study was carried out in accordance with ...
Urban Milwaukee18d
MU Unveils 2025 Non-Conference Volleyball Schedule
MILWAUKEE – Marquette University women’s volleyball first-year head coach Tom Mendoza has announced MU’s non-conference schedule for the fall of 2025, featuring the match against Wisconsin ...
Road to VR19d
‘Alien: Rogue Incursion’ is Getting a Non-VR Version Later This Year
Like the VR version, Survios says the flatscreen release will be ‘Part One’ of ... or whether the studio hopes to similarly stagger its VR and non-VR releases, or otherwise package both ...
Stockhouse19d
Matador Technologies Inc. Announces Non-Brokered Private Placement
TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MATAF), a Bitcoin-focused technology ...
PharmiWeb21d
Global Non-Fusion Spinal Devices Market Set to Surge as Demand for Mobility-Preserving Treatments Grows | FMI
The global non-fusion spinal devices market is poised for significant growth over the next decade, driven by a surge in spinal disorders, a rapidly aging global population, and ongoing advancements in ...